MEDICS CHOICE EYE DROPS MAXIMUM REDNESS RELIEF- glycerin, naphazoline hydrochloride solution 
K.C. Pharmaceuticals, Inc.

----------

Medic's Choice Eye Drops Maximum Redness Relief 15 mL

Active ingredients

Glycerin.....0.5%

Naphazoline hydrochloride....0.03%

Purpose

Glycerin..................................Lubricant

Naphazoline hydrochloride.....Redness reliever

Uses

Warnings

For external use only

Do not use if solution changes color or becomes cloudy

Ask a doctor before use if you have narrow angle glaucoma

When using this product

  • To avoid contamination, do not touch tip of container to any surface
  • Replace cap after using
  • Overuse may produce increased redness of the eye
  • Pupils may become enlarged temporarily

Stop use and ask a doctor if

  • you experience eye pain
  • you experience changes in vision
  • you experience continued redness or irritation of the eye
  • the condition worsens or persists for more than 72 hours

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

Directions

Inatill 1 or 2 drops in the affected eye(s) up to 4 times daily.

Other information

Inactive ingredients

benzalkonium chloride, boric acid, edetate disodium, purified water, sodium borate

box

MEDICS CHOICE EYE DROPS MAXIMUM REDNESS RELIEF 
glycerin, naphazoline hydrochloride solution
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:55651-059
Route of AdministrationOPHTHALMIC
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GLYCERIN (UNII: PDC6A3C0OX) (GLYCERIN - UNII:PDC6A3C0OX) GLYCERIN0.5 g  in 100 mL
NAPHAZOLINE HYDROCHLORIDE (UNII: MZ1131787D) (NAPHAZOLINE - UNII:H231GF11BV) NAPHAZOLINE HYDROCHLORIDE0.03 g  in 100 mL
Inactive Ingredients
Ingredient NameStrength
BENZALKONIUM CHLORIDE (UNII: F5UM2KM3W7)  
WATER (UNII: 059QF0KO0R)  
SODIUM BORATE (UNII: 91MBZ8H3QO)  
BORIC ACID (UNII: R57ZHV85D4)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:55651-059-011 in 1 CARTON03/27/2023
115 mL in 1 BOTTLE, DROPPER; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01803/27/2023
Labeler - K.C. Pharmaceuticals, Inc. (174450460)
Establishment
NameAddressID/FEIBusiness Operations
K.C. Pharmaceuticals, Inc.174450460manufacture(55651-059) , pack(55651-059) , label(55651-059)

Revised: 12/2023
Document Id: 0d29e40f-48bd-800a-e063-6394a90a48d9
Set id: f7131707-47af-d70a-e053-6394a90a418f
Version: 2
Effective Time: 20231223
 
K.C. Pharmaceuticals, Inc.